KCM Investment Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-1,651
| Closed | -$224K | – | 403 |
|
2021
Q2 | $224K | Sell |
1,651
-875
| -35% | -$119K | 0.01% | 364 |
|
2021
Q1 | $343K | Buy |
2,526
+300
| +13% | +$40.7K | 0.02% | 296 |
|
2020
Q4 | $313K | Hold |
2,226
| – | – | 0.02% | 285 |
|
2020
Q3 | $248K | Hold |
2,226
| – | – | 0.01% | 287 |
|
2020
Q2 | $249K | Buy |
+2,226
| New | +$249K | 0.01% | 295 |
|
2019
Q1 | – | Sell |
-5,710
| Closed | -$410K | – | 363 |
|
2018
Q4 | $410K | Hold |
5,710
| – | – | 0.03% | 366 |
|
2018
Q3 | $547K | Hold |
5,710
| – | – | 0.03% | 338 |
|
2018
Q2 | $544K | Sell |
5,710
-1,705
| -23% | -$162K | 0.03% | 334 |
|
2018
Q1 | $651K | Sell |
7,415
-813
| -10% | -$71.4K | 0.04% | 320 |
|
2017
Q4 | $698K | Buy |
8,228
+1,571
| +24% | +$133K | 0.04% | 308 |
|
2017
Q3 | $576K | Sell |
6,657
-2,884
| -30% | -$250K | 0.04% | 326 |
|
2017
Q2 | $736K | Sell |
9,541
-2,501
| -21% | -$193K | 0.05% | 291 |
|
2017
Q1 | $835K | Buy |
12,042
+6,102
| +103% | +$423K | 0.05% | 272 |
|
2016
Q4 | $352K | Buy |
5,940
+150
| +3% | +$8.89K | 0.02% | 410 |
|
2016
Q3 | $384K | Buy |
5,790
+1,175
| +25% | +$77.9K | 0.03% | 411 |
|
2016
Q2 | $250K | Hold |
4,615
| – | – | 0.02% | 467 |
|
2016
Q1 | $238K | Hold |
4,615
| – | – | 0.02% | 469 |
|
2015
Q4 | $324K | Hold |
4,615
| – | – | 0.03% | 398 |
|
2015
Q3 | $287K | Sell |
4,615
-2,999
| -39% | -$187K | 0.02% | 424 |
|
2015
Q2 | $640K | Sell |
7,614
-3,000
| -28% | -$252K | 0.05% | 314 |
|
2015
Q1 | $798K | Hold |
10,614
| – | – | 0.06% | 273 |
|
2014
Q4 | $660K | Buy |
10,614
+6
| +0.1% | +$373 | 0.06% | 294 |
|
2014
Q3 | $552K | Hold |
10,608
| – | – | 0.05% | 302 |
|
2014
Q2 | $545K | Hold |
10,608
| – | – | 0.05% | 301 |
|
2014
Q1 | $504K | Hold |
10,608
| – | – | 0.05% | 290 |
|
2013
Q4 | $460K | Hold |
10,608
| – | – | 0.05% | 296 |
|
2013
Q3 | $457K | Buy |
+10,608
| New | +$457K | 0.05% | 293 |
|